Skip to main content

Table 4 Independent correlates of highest modified Rodnan skin score recorded during follow-up, determined using linear regression

From: Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

Variable a

Parameter estimate

Standard error

P value

Anti-topoisomerase antibodies

4.37

0.98

< 0.0001

Anti-RNA polymerase III antibodies

7.67

1.09

< 0.0001

Joint contractures

8.47

0.81

< 0.0001

  1. aEver from disease onset (defined as date of onset of first systemic-sclerosis-related manifestation other than Raynaud's phenomenon) to most recent visit.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us